TECHWIRE 30
(CIX: WRAL30)  1,112.74  down arrow-15.07  (-1.34 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Apple)  117.16  down arrow-1.74  (-1.46 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: QUINTILES)  60.50  down arrow-1.26  (-2.04 %)  Updated: 06:40 PM EST, Jan 30 2015
(OP: BASF SE)  89.56  down arrow-0.76  (-0.84 %)  Updated: 05:20 PM EST, Jan 30 2015
(NQ: BioCryst)  10.18  down arrow-0.5  (-4.68 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: BioDelivery)  13.10  down arrow-0.53  (-3.89 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: CEMP)  27.74  down arrow-0.23  (-0.82 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Cisco Systems)  26.37  down arrow-0.86  (-3.14 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Cree)  35.36  down arrow-0.39  (-1.09 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: DARA)  0.84  down arrow-0.02  (-2.34 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: EMC CORPORATION)  25.93  down arrow-0.47  (-1.78 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: Extreme Networks)  2.94  down arrow-0.1  (-3.29 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: FB)  75.91  down arrow-2.09  (-2.68 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: GLAXOSMITHKLINE)  44.00  down arrow-1.16  (-2.57 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: GOOG)  534.52  up arrow+23.86  (4.67 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: IBM)  153.31  down arrow-2.17  (-1.4 %)  Updated: 06:40 PM EST, Jan 30 2015
(NY: LH)  114.78  down arrow-1.34  (-1.15 %)  Updated: 06:40 PM EST, Jan 30 2015
(OP: Lenovo Group)  25.64  down arrow-0.22  (-0.85 %)  Updated: 05:20 PM EST, Jan 30 2015
(NY: MRK)  60.28  down arrow-1.81  (-2.92 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: Microsoft Corp)  40.40  down arrow-1.61  (-3.83 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: NTAP)  37.80  down arrow-0.26  (-0.68 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: NOVARTIS AG)  97.40  down arrow-1.76  (-1.77 %)  Updated: 06:40 PM EST, Jan 30 2015
(OP: Novozymes A/S)  45.65  up arrow+0.08  (0.18 %)  Updated: 05:20 PM EST, Jan 30 2015
(NY: PFIZER)  31.25  down arrow-0.58  (-1.82 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: Pozen)  6.91  down arrow-0.17  (-2.4 %)  Updated: 08:10 PM EST, Jan 30 2015
(NY: RED HAT)  63.79  down arrow-1.96  (-2.98 %)  Updated: 06:40 PM EST, Jan 30 2015
(NQ: BBRY)  10.15  down arrow-0.1  (-0.98 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: Salix)  134.67  down arrow-0.47  (-0.35 %)  Updated: 08:10 PM EST, Jan 30 2015
(NQ: SQI)  14.22  down arrow-0.04  (-0.28 %)  Updated: 08:10 PM EST, Jan 30 2015

Posts tagged “N.C. Biotech Center”

5:48 a.m. Monday

Are you making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

January 23

White Labs bringing fermenting sciences, 65 jobs to Asheville

White Labs, a world leader in fermentation sciences for the brewing and winemaking industries, has announced the purchase of a 26,000-square-foot building in Asheville, with plans to employ 65 people - a mix of scientists, production and distribution personnel.

Vice President Lisa White of White Labs at new facility Vice President Lisa White of White Labs at new facility

January 19

Making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

January 12

Making news? Have an opinion? Share it with WTW

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

January 8

Medical device firm is expanding, planning to hire in Charlotte

Help wanted sign    If you need complex medical devices, Medical Murray Southeast is quickly becoming a major regional resource for design, development, manufacturing and even sales of the specialty products.

January 6

RTP drug startup Dignify Therapeutics lands $330,000 Biotech Center loans

Dignify Therapeutics The North Carolina Biotechnology Center has awarded two loans in two years totaling $300,000 to help propel a young Research Triangle Park drug company with a unique product line: Dignify Therapeutics.

January 5

Raleigh's Innovate Biopharma purchases drug candidate

Looking for drugs Raleigh's Innovate Biopharmaceuticals has purchased a synthetic version of a human hormone for diagnosing pancreatic disease from Boston-area biotech company Repligen.

January 5

Your company making news? Have an opinion? Share it with WTW

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

December 29, 2014

Premium Lock Making news? Have an opinion? Share it with WTW

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated December 24, 2014

Premium Lock FDA approves BioCryst's flu treatment - a 'great day for NC biotech'

Drug deal In what BioCryst President and CEO Jon Stonehouse called a "great day for North Carolina biotech," the Durham company is leading a celebration for U.S. Food and Drug Administration approval of its intravenous flu treatment.

December 22, 2014

Premium Lock Are you, your company making news? Have an opinion? Share it with WTW

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated December 16, 2014

Premium Lock Despite layoffs at GSK, raise a glass (at least) half full

Veteran journalist Jim Shamp sees upside and downside in the recently announced job cuts at GlaxoSmithKline. After all, he notes, cuts in the past as GSK evolved locally from Burrough Wellcome to Glaxo to Glaxo Wellcome and today have produced a harvest of new companies, new ideas, and products. "Yes, a shakeup like GSK's cutback announcement is shattering," he writes. "But these are smart, talented people who will get back on their feet and contribute greatly to North Carolina's life science future."

GSK Headquarters      GSK Headquarters

December 15, 2014

Premium Lock Is your company making news? Have an opinion? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated December 9, 2014

Premium Lock NC firms help lead Ebola fight but face multiple battles

Several North Carolina firms are at the forefront of developing new treatments for the Ebola virus, but they face challenges in testing and delivering them, executives from Chimerix, Quintiles and GlaxoSmithKline say at a conference in RTP.

GSK's Donna Altenpohl GSK's Donna Altenpohl

Updated December 9, 2014

Premium Lock North Carolina is at forefront of fighting Ebola threat

Ebola North Carolina is on the forefront of preparation for a potential Ebola crisis as well as helping fight global outbreaks of the dreaded disease, said representatives from the state and national government, the Triangle health care profession, and Triangle private industry at Monday's Ebola Conference at the North Carolina Biotechnology Center.

Updated December 9, 2014

Premium Lock North Carolina's role in fighting Ebola highlights conference in RTP

Ebola North Carolina's role in fighting the Ebola epidemic striking western Africa and a disease that is a global threat will be discussed Monday at a conference in Research Triangle Park.

December 8, 2014

Premium Lock Making news? Have an opinion? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated December 5, 2014

Premium Lock Ebola NC: Conference to focus on state's role, preparations in fighting outbreak

Ebola Government, health, private sector executives will gather at a conference focusing on the Ebola outbreak and North Carolina's involvement as well as preparations for a possible health crisis here.

December 1, 2014

Premium Lock Your company making news? Have an opinion? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

November 25, 2014

Premium Lock Grifols' $370M Clayton plant receives FDA approval

Blood therapeutics company Grifols has received approval from the U.S. Food and Drug Administration to sell products in the United States that are produced at Grifols' $370 million Clayton manufacturing addition, according to a news report.

Inside a Grifols plant Inside a Grifols plant

Techwire Inside Partners
The Skinny: A Blog by Rick Smith